insights_auto
Why is SABS down 3.90%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
$2.96
arrow_downward
-3.90%(-0.12) 1D
Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
$3.08
High
$3.15
Low
$2.85
Mkt. cap
266.66M
Avg. vol.
700.24K
Volume
658.12K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
Open
$3.08
High
$3.15
Low
$2.85
Mkt. cap
266.66M
Avg. vol.
700.24K
Volume
658.12K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
News stories
From web sources and news partners
The Motley Fool
·
27 minutes ago
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
Bloomberg.com
·
1 hour ago
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Trefis
·
8 hours ago
S&P 500 Movers | Winners: CHTR, STE, GPN | Losers: AMD, DELL, CSCO
Traders Union
·
3 hours ago
Gold volatility surpasses S&P 500 by 2.1 times, Mike McGlone notes
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Florida, United States
SectorHealth Care
IndustryBiotechnology
Websitesab.bio